中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 42 Issue 3
Mar.  2026
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2026  >  42(3): 647-654

Risk factors for lower extremity deep vein thrombosis in patients with acute necrotizing pancreatitis and effectiveness of risk assessment models

DOI: 10.12449/JCH260320
  • 1.

    Department of General Surgery （Hepatobiliary and Pancreatic Surgery），The Affiliated Hospital of Southwest Medical University，Luzhou，Sichuan 646000，China

  • 2.

    Department of General Surgery （Hepatobiliary，Pancreatic and Spleen Surgery），Luzhou People’s Hospital，Luzhou，Sichuan 646000，China

Research funding:

Sichuan Medical Research Project (S23003)

More Information
  • Corresponding author: LI Bo， liboer2002@126.com （ORCID： 0009-0000-8191-2201）
  • Received Date: 2025-05-18
  • Accepted Date: 2025-11-18
  • Published Date: 2026-03-25
    Abstract
  •   Objective  To investigate the influencing factors and independent risk factors for lower extremity deep vein thrombosis （DVT） in patients with acute necrotizing pancreatitis （ANP）， to analyze the effectiveness of three commonly used risk assessment models for thrombosis （Caprini score， Padua score， and Wells score）， and to provide a reference for clinical identification of high-risk individuals and optimization of prevention and treatment strategies.  Methods  A retrospective analysis was performed for the clinical data of 320 patients with ANP who were admitted to Luzhou People’s Hospital and The Affiliated Hospital of Southwest Medical University from April 2013 to April 2024， and according to the presence or absence of DVT during hospitalization， the patients were divided into thrombosis group with 25 patients and control group with 295 patients. After propensity score matching， the two groups were compared in terms of past history and various examination results during hospitalization. The risk factors for lower extremity DVT in ANP patients during hospitalization were analyzed through univariate and multivariate Logistic regression， and a DVT risk prediction model was established based on independent influencing factors. The receiver operating characteristic （ROC） curve was used to assess the performance of models， and the DeLong test was used for comparison of the area under the ROC curve （AUC）， sensitivity， and specificity. The independent-samples t test or the Mann-Whitney U test was used for comparison of continuous data between two groups； the chi-square test was used for comparison of categorical data between groups.  Results  After matching， the patients were divided into thrombosis group with 24 patients and control group with 112 patients. The clinical characteristics analysis showed that compared with the control group， the thrombosis group had significantly higher degree of pancreatic necrosis， D-dimer level， Bedside Index for Severity in Acute Pancreatitis （BISAP） score， and proportion of patients undergoing dialysis （all P<0.05）. The multivariable Logistic regression analysis showed that BISAP score， degree of pancreatic necrosis， and D-dimer level were independent risk factors for lower extremity DVT in ANP patients during hospitalization （all P<0.05）. The BISAP-Caprini score model had an AUC of 0.832 （95% confidence interval： 0.722 — 0.942， P<0.001） in predicting the risk of lower extremity DVT， with a Youden index of 1.661， an optimal cut-off value of 0.26， a sensitivity of 75.0%， and a specificity of 91.1%.  Conclusion  D-dimer， BISAP score， and the degree of pancreatic necrosis are independent risk factors for lower extremity DVT in patients with ANP during hospitalization， and the BISAP-Caprini score model can effectively predict the risk of DVT in ANP patients.

     

    • FullText(HTML)
  • loading
    • References(28)
  • [1]
    GLIEM N, AMMER-HERRMENAU C, ELLENRIEDER V, et al. Management of severe acute pancreatitis: An update[J]. Digestion, 2021, 102( 4): 503- 507. DOI: 10.1159/000506830.
    [2]
    WU HS, MA KQ, LIAO BL, et al. Guiding effect of noninvasive monitoring of cardiac output and central venous oxygen saturation on early goal-directed fluid resuscitation in hyperlipidemic severe acute pancreatitis[J]. J Clin Hepatol, 2022, 38( 7): 1602- 1607. DOI: 10.3969/j.issn.1001-5256.2022.07.026.

    巫泓生, 马克强, 廖碧玲, 等. 无创心排量联合中心静脉血氧饱和度监测对高脂血症性重症胰腺炎早期目标导向性液体复苏的指导作用[J]. 临床肝胆病杂志, 2022, 38( 7): 1602- 1607. DOI: 10.3969/j.issn.1001-5256.2022.07.026.
    [3]
    ZHAO CS, YAO WJ, YUAN P, et al. Time distribution of risk factors for secondary pancreatic infection in acute pancreatitis[J]. J Clin Hepatol, 2022, 38( 7): 1686- 1690. DOI: 10.3969/j.issn.1001-5256.2022.07.044.

    赵成思, 姚维杰, 袁鹏, 等. 急性胰腺炎继发胰腺感染的危险因素及其时间分布[J]. 临床肝胆病杂志, 2022, 38( 7): 1686- 1690. DOI: 10.3969/j.issn.1001-5256.2022.07.044.
    [4]
    SURYAWANSHI G, JONASON DE, MUNIGALA S, et al. Incidence and risk factors for deep vein thrombosis(DVT) and pulmonary embolism(PE) in acute necrotizing pancreatitis(ANP)-A single center experience[J]. Pancreatology, 2024, 24( 6): 856- 862. DOI: 10.1016/j.pan.2024.07.007.
    [5]
    CHUNG WS, LIN CL. Association between venous thromboembolism and acute pancreatitis: An analysis from the nationwide inpatient sample[J]. Clin Respir J, 2020, 14( 4): 320- 327. DOI: 10.1111/crj.13134.
    [6]
    AHMAD DS, MANSOOR E, ALIKHAN MM, et al. Risk of venous thromboembolism in acute necrotizing pancreatitis: A large database study[J]. Pancreas, 2021, 50( 1): 71- 76. DOI: 10.1097/MPA.0000000000001714.
    [7]
    CHENG JH, LIU ZD. Incidence and risk factors of lower extremity deep venous thrombosis in severe acute pancreatitis patients during intensive care unit period[J]. J Clin Emerg, 2021, 22( 9): 597- 602. DOI: 10.13201/j.issn.1009-5918.2021.09.006.

    程家浩, 刘正东. 重症急性胰腺炎患者ICU期间下肢深静脉血栓形成的发生率和危险因素分析[J]. 临床急诊杂志, 2021, 22( 9): 597- 602. DOI: 10.13201/j.issn.1009-5918.2021.09.006.
    [8]
    BANKS PA, BOLLEN TL, DERVENIS C, et al. Classification of acute pancreatitis 2012: revision of the Atlanta classification and definitions by international consensus[J]. Gut, 2013, 62( 1): 102- 111. DOI: 10.1136/gutjnl-2012-302779.
    [9]
    LUO XP, WANG J, WU Q, et al. Research advances in acute pancreatitis scoring system[J]. J Clin Hepatol, 2022, 38( 9): 2188- 2192. DOI: 10.3969/j.issn.1001-5256.2022.09.046.

    罗秀平, 王洁, 吴青, 等. 急性胰腺炎评分系统的研究进展[J]. 临床肝胆病杂志, 2022, 38( 9): 2188- 2192. DOI: 10.3969/j.issn.1001-5256.2022.09.046.
    [10]
    WU BU, JOHANNES RS, SUN X, et al. The early prediction of mortality in acute pancreatitis: a large population-based study[J]. Gut, 2008, 57( 12): 1698- 1703. DOI: 10.1136/gut.2008.152702.
    [11]
    SAMANTA J, DHAR J, GUPTA P, et al. Venous thrombosis in acute pancreatitis: What to and not to do[J]. Dig Dis Sci, 2024, 69( 5): 1537- 1550. DOI: 10.1007/s10620-024-08418-5.
    [12]
    SINGH RR, THANDASSERY RB, CHAWLA S. Acute venous thromboembolism is common following acute necrotizing pancreatitis and is associated with worse clinical outcomes[J]. Pancreas, 2024, 53( 10): e802- e807. DOI: 10.1097/MPA.0000000000002375.
    [13]
    WENGER N, SEBASTIAN T, ENGELBERGER RP, et al. Pulmonary embolism and deep vein thrombosis: Similar but different[J]. Thromb Res, 2021, 206: 88- 98. DOI: 10.1016/j.thromres.2021.08.015.
    [14]
    Pulmonary Embolism& Pulmonary Vascular Diseases Group of the Chinese Thoracic Society, Pulmonary Embolism& Pulmonary Vascular Disease Working Group of Chinese Association of Chest Physicians, National Cooperation Group on Prevention& Treatment of Pulmonary Embolism& Pulmonary Vascular Disease. Chinese guidelines for the diagnosis, treatment, prophylaxis and management of pulmonary thromboembolism(2025 edition)[J]. Natl Med J China, 2025, 105( 26): 2162- 2194. DOI: 10.3760/cma.j.cn112137-20250509-01141.

    中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 中国肺血栓栓塞症诊治、预防和管理指南(2025版)[J]. 中华医学杂志, 2025, 105( 26): 2162- 2194. DOI: 10.3760/cma.j.cn112137-20250509-01141.
    [15]
    TRIKUDANATHAN G, UMAPATHY C, MUNIGALA S, et al. Venous thromboembolism is associated with adverse outcomes in hospitalized patients with acute pancreatitis: A population-based cohort study[J]. Pancreas, 2017, 46( 9): 1165- 1172. DOI: 10.1097/MPA.0000000000000906.
    [16]
    GLAUBITZ J, ASGARBEIK S, LANGE R, et al. Immune response mechanisms in acute and chronic pancreatitis: Strategies for therapeutic intervention[J]. Front Immunol, 2023, 14: 1279539. DOI: 10.3389/fimmu.2023.1279539.
    [17]
    KELLER K, SIVANATHAN V, FARMAKIS IT, et al. Incidence and impact of venous thromboembolism in hospitalized patients with acute pancreatitis[J]. Dig Liver Dis, 2024, 56( 12): 2085- 2094. DOI: 10.1016/j.dld.2024.06.023.
    [18]
    ROCH AM, MAATMAN TK, CARR RA, et al. Venous thromboembolism in necrotizing pancreatitis: An underappreciated risk[J]. J Gastrointest Surg, 2019, 23( 12): 2430- 2438. DOI: 10.1007/s11605-019-04124-0.
    [19]
    CAPURSO G, PONZ DE LEON PISANI R, LAURI G, et al. Clinical usefulness of scoring systems to predict severe acute pancreatitis: A systematic review and meta-analysis with pre and post-test probability assessment[J]. United European Gastroenterol J, 2023, 11( 9): 825- 836. DOI: 10.1002/ueg2.12464.
    [20]
    ALI H, MOOND V, VIKASH F, et al. Risk score to predict inpatient mortality of acute pancreatitis patients admitted to the intensive care unit[J]. Pancreatology, 2024, 24( 8): 1213- 1218. DOI: 10.1016/j.pan.2024.10.010.
    [21]
    ZHU JP, WU LF, WANG Y, et al. Predictive value of the Ranson and BISAP scoring systems for the severity and prognosis of acute pancreatitis: A systematic review and meta-analysis[J]. PLoS One, 2024, 19( 4): e0302046. DOI: 10.1371/journal.pone.0302046.
    [22]
    PANDOR A, TONKINS M, GOODACRE S, et al. Risk assessment models for venous thromboembolism in hospitalised adult patients: A systematic review[J]. BMJ Open, 2021, 11( 7): e045672. DOI: 10.1136/bmjopen-2020-045672.
    [23]
    ROCHA D, LOBATO CT, MELO PINTO D, et al. Venous thromboembolism prophylaxis in medical and surgical patients- what’s our reality[J]. Cureus, 2023, 15( 11): e49444. DOI: 10.7759/cureus.49444.
    [24]
    CHEN XL, HUANG JL, LIU JX, et al. Venous thromboembolism risk factors and prophylaxis of elderly intensive care unit patients in a Chinese general hospital[J]. Ann Palliat Med, 2021, 10( 4): 4453- 4462. DOI: 10.21037/apm-21-464.
    [25]
    ZHANG X, HAO AQ, LU YH, et al. Deep vein thrombosis and validation of the Caprini risk assessment model in Chinese orthopaedic trauma patients: A multi-center retrospective cohort study enrolling 34, 893 patients[J]. Eur J Trauma Emerg Surg, 2023, 49( 4): 1863- 1871. DOI: 10.1007/s00068-023-02265-1.
    [26]
    ZHOU H, HU Y, LI X, et al. Assessment of the risk of venous thromboembolism in medical inpatients using the padua prediction score and caprini risk assessment model[J]. J Atheroscler Thromb, 2018, 25( 11): 1091- 1104. DOI: 10.5551/jat.43653.
    [27]
    XIONG W, CHENG Y, ZHAO YF. Risk scores in venous thromboembolism guidelines of ESC, ACCP, and ASH: An updated review[J]. Clin Appl Thromb Hemost, 2024, 30: 10760296241263856. DOI: 10.1177/10760296241263856.
    [28]
    SUN JM, SONG JM, PAN JH, et al. Analysis of treatment strategies and safety for acute deep vein thrombosis of the lower extremities[J]. Chin J Med Offic, 2025, 53( 10): 1019- 1023, 1028. DOI: 10.16680/j.1671-3826.2025.10.06.

    孙健铭, 宋家明, 潘江皓, 等. 急性下肢深静脉血栓形成治疗策略及安全性分析[J]. 临床军医杂志, 2025, 53( 10): 1019- 1023, 1028. DOI: 10.16680/j.1671-3826.2025.10.06.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (27) PDF downloads(12) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return